2026 FDLI Annual Conference
May 6–7, 2026 | Washington, DC & Virtual Event
Overview
Conference Highlights
- Hear FDA’s strategic priorities directly from the FDA Commissioner and other key leaders within the agency and Health and Human Services invited to speak
- Join high-level colleagues in food and drug law to hear different viewpoints, shape policy, and advance understanding
- Participate in over 30 sessions covering the latest in legal, regulatory, compliance, policy, marketing, and related issues to enjoy targeted for your key interests
- Learn from more than 100 well-known officials and experts
- Hear about the Top Cases in Food and Drug Law
- Network and build relationships with seasoned legal, regulatory, compliance, policy, and government professionals
Register
Call for Proposals
Sponsors
Premier
Diamond
Gold
Silver
Bronze
Lanyard
Planning Committee

Kalah Auchincloss
Co-Chair
Auchincloss Legal

Sharon Mayl
Co-Chair
DLA Piper LLP (US)
Committee Members
Anna K. Abram, Akin
Laura J. Akowuah, Cooley LLP
John Claud, Hyman, Phelps & McNamara, PC
Andrea G. Ferrenz, The Campbell’s Company
Eric Fish, ProPharma Group
Jack C. Garvey, Compliance Architects LLC
Lewis A. Grossman, American University
Dorothy K. Hatsukami, University of Minnesota
Matthew Hegreness, Covington & Burling LLP
Jeremiah J. Kelly, Venable LLP
Coleen E. Klasmeier, Roche Diagnostics/BMC
Paige Magness, Altria Client Services LLC
Rachael G. Pontikes, Blank Rome, LLP
Margaret (Mimi) Foster Riley, University of Virginia
Schevon Salmon, K&L Gates LLP
Ariel Seeley, Morgan, Lewis & Bockius LLP
Lance L. Shea, Foley Hoag LLP
Sarah Sorscher, Center for Science in the Public Interest
Stuart TenHoor, Stuart TenHoor Legal Search
Rachel Turow, Skadden, Arps, Slate, Meagher & Flom LLP
James Wabby, AbbVie
Jennifer Zachary, Merck & Co., Inc.
Jessica Zeller, Edwards Lifesciences LLC





